$14.99
Research Studies:
FREE Shipping on
orders over $200
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
Bacteriostatic Water 10mL is a research-use-only laboratory material supplied for controlled research workflows, laboratory documentation review, and handling support in qualified research settings. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification where applicable.
Bacteriostatic Water 10mL is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
| CAS No. | 7732-18-5 (Water), 100-51-6 (Benzyl Alcohol) |
|---|---|
| Molecular Formula | C78H123N23O23S2 |
| Molecular Weight | 1815.08 g/mol |
| Purity | ≥99% |
| Sequence | Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe |
| Synthesis Method | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Water/Sterile Diluent |
| Stability & Storage | Up to 24 months at -20°C. Avoid repeated freeze-thaw cycles. |
| Applications | Peptide reconstitution, laboratory solvent, research diluent |
| Appearance | White to off-white powder |
| Regulatory/Compliance | Not for human consumption. For research use only. |
| Safety Information | MSDS available upon request |
| Concentration | 0.9% Benzyl Alcohol in Sterile Water |
| Volume | 10ml |
Consider these supplementary peptides for a comprehensive research approach.
Researchers who buy bacteriostatic water for research should treat the product page as a documentation checkpoint, not a consumer guide. Official label records commonly describe bacteriostatic water as sterile, non-pyrogenic water with benzyl alcohol added as a preservative, while preservative-free sterile water records distinguish materials without a bacteriostat [1] [2]. This Pure Lab Peptides guide focuses on RUO labeling, COA review, analytical testing, supplier documentation, and lot-level traceability for laboratory procurement.
Bacteriostatic water is best evaluated as a sterile laboratory material with an identity record, preservative record, container record, and batch record.
The core composition context is water plus benzyl alcohol, with PubChem listing water as H₂O and benzyl alcohol as C₇H₈O [4] [5].
Sterile water and saline comparisons should stay technical because different label records describe different compositions and preservative status [2] [3].
Product-page readers should review COA availability, lot number consistency, label clarity, storage documentation, and supplier records before procurement.
Literature and official label records can clarify terminology, but they should not become product claims for RUO materials.
Analytical review should separate identity, purity, sterility-related documentation, endotoxin-related documentation, and lot traceability.
RUO boundaries mean the page should support qualified laboratory research procurement without personal-use, clinical-use, therapeutic-use, or consumer-outcome positioning.
To buy bacteriostatic water for research, review RUO labeling, batch-specific COA documentation, preservative identity, sterile-material records, lot number consistency, and supplier documentation before procurement. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption. Official label records can clarify technical terminology, but Pure Lab Peptides product pages remain RUO-focused [1].
Start with documents that prove the listing is specific, traceable, and research-focused. A strong product-page record should identify the material name, lot number, COA date, testing basis, storage notes, label status, and supplier documentation.
For research buyers, the first question is not whether the listing sounds familiar. The better question is whether the label, COA, and batch records tell the same story.
The phrase buy bacteriostatic water for research should lead to documentation review, not consumer-style comparison. In a technical procurement workflow, the commercial step comes after the lab team has checked RUO status, material identity, and available batch records.
That review is especially important when bacteriostatic water appears near peptide research listings. The solvent record and the peptide COA should remain separate but compatible pieces of the same documentation package.
RUO labeling should be visible, consistent, and reinforced by the surrounding copy. It should not be buried below claims, vague product language, or unsupported quality statements.
A safer supplier page keeps the focus on research documentation: product identity, COA access, lot traceability, and handling records. FDA’s CGMP data-integrity guidance emphasizes that regulated-quality records should be reliable and accurate, a useful documentation principle even when an RUO page is not making regulated-product claims [11].
RUO context means the page is written for qualified laboratory research evaluation. It is not a personal-use buying guide, and it does not convert official labels, literature, or technical vocabulary into product-use claims.
For Pure Lab Peptides, bacteriostatic water content should help researchers understand what to check: identity, preservative context, sterility-related documentation, supplier records, and lot-level consistency.
RUO labeling should clarify that the material is offered for laboratory research only. It should also make clear that product-page content is educational and procurement-focused.
The strongest pages pair that statement with concrete documentation. Labeling claims without supporting records are weaker than a clear COA, matched lot number, and technical storage record.
Commercial language is not unsafe by itself. The risk appears when buy-intent becomes consumer intent.
A research-safe page can acknowledge procurement intent while staying anchored to documentation. That is why the safe primary keyword is buy bacteriostatic water for research, not an unsupported consumer-buy phrase.
Bacteriostatic water is a sterile aqueous material whose official label records describe water with benzyl alcohol added as a preservative [1]. In laboratory documentation, the important details are the base water identity, preservative identity, container description, lot number, pH range if listed, and COA support.
Water has the molecular formula H₂O and molecular weight 18.015 g/mol in PubChem [4]. Benzyl alcohol is listed by PubChem with molecular formula C₇H₈O and molecular weight 108.14 g/mol [5].
That matters because product-page language should name the preservative clearly. A COA or supplier record should not leave researchers guessing whether the listing refers to bacteriostatic water, sterile water, preserved saline, or another aqueous material.
Non-pyrogenic water language belongs in documentation because endotoxin-related quality is a distinct technical concept. USP maintains a Bacterial Endotoxins Test general chapter, and FDA technical guidance explains that endotoxin concerns are tied to water systems, microbial history, and process controls [8] [10].
A product page should not treat “sterile” and “nonpyrogenic” as interchangeable. They are separate documentation signals.
On a product page, bacteriostatic water should function as a research material listing with clear documentation. The page should not shift into wellness, clinical, or procedure-focused language.
A useful layout puts the document trail close to the product identity. Researchers should be able to find RUO status, COA availability, supplier details, lot information, and storage documentation without digging through unrelated claims.
A clean research listing separates what the material is from what the page is not claiming. For bacteriostatic water, identity language can describe water, benzyl alcohol, sterile context, vial or bottle format, and batch records.
What the page should avoid is converting those identity details into product performance claims. Documentation is the point.
Above the fold, the page should show the product name, RUO status, key identity statement, COA access, lot-specific documentation policy, and storage summary. If a catalog specification appears, it should be treated as listing information only.
Research buyers should not need to infer whether the page is meant for laboratory procurement. The page should make that clear immediately.
Sterile water, bacteriostatic water, and preserved saline can look similar in casual search language, but official label records distinguish them by composition and preservative status. Preservative-free sterile water records state that the material contains no bacteriostat, antimicrobial agent, or added buffer [2]. Preserved saline records identify sodium chloride and benzyl alcohol as separate components [3].
Benzyl alcohol belongs in identity context because it is the preservative component that differentiates bacteriostatic water from preservative-free sterile water in official label records [1]. It should be described as a chemical identity and documentation point, not as a product claim.
The phrase “benzyl alcohol as a preservative” is acceptable when tied to composition records. It becomes unsafe only when it is framed as personal-use guidance.
Sterile water and saline comparisons should remain technical. Sodium chloride has the formula NaCl and molecular weight 58.44 g/mol in PubChem, which supports a composition-based distinction between saline and water-based materials [6].
For a research page, the comparison should answer one question: what does each label or COA say? It should not tell readers how to apply one material in a personal setting.
Material compatibility is a laboratory documentation topic. It concerns whether the surrounding records accurately describe the aqueous material, preservative status, container, lot, and related research material listings.
For peptide research pages, this matters because the diluent record should be separate from peptide identity records. Synthetic peptide characterization often uses mass spectrometry and LC-MS to confirm peptide identity and purity, while water or preserved-water materials may rely on different COA attributes [18].
Aqueous diluent language should stay tied to documentation. It can describe solvent class, preservative status, pH range when listed, sterility-related documentation, and container format.
It should not become a preparation guide. The page’s role is to help research teams compare documents, not to instruct practical application.
Peptide research listings often include COA details such as HPLC purity, mass confirmation, lot number, and test date. HPLC has long been used in synthetic peptide analysis, and mass spectrometry is well suited for confirming synthetic peptide identity and purity [18] [19].
Bacteriostatic water documentation should sit beside that record set. It should not be blended into peptide claims.
Published sources and official records frame bacteriostatic water through composition, sterility-related terminology, preservative identity, and container documentation. DailyMed label records are useful for terminology, while USP and FDA sources help explain sterility, endotoxin, container integrity, and quality-record concepts [1] [7] [9].
Literature and official databases can clarify what a preservative is, how benzyl alcohol is identified, and how it differs from water or sodium chloride at the compound level [4] [5] [6]. That is enough for a research product page.
The page does not need to go beyond identity context. Preservative language should remain a label and COA topic.
Official label records are not product claims for RUO materials. They are terminology sources.
The safer editorial approach is to say what the records describe, cite them, and return to procurement documentation. That keeps the product page grounded without borrowing claims from another context.
A documentation-led product page needs an evidence filter. Not all evidence categories answer the same question, and not all sources belong on a research product page.
| Research Area | What Literature Examines | Evidence Type | RUO Interpretation |
|---|---|---|---|
| Compound identity | Water, benzyl alcohol, and sodium chloride have distinct molecular records [4] [5] [6] | Official database | Supports identity wording, not product claims |
| Sterile-material documentation | USP and FDA sources describe sterility testing, endotoxin testing, and container integrity concepts [7] [8] [9] | Official standards and guidance | Supports documentation review |
| Analytical method review | ICH Q2(R2) and Q14 frame validation and development of analytical procedures [16] [17] | Official guidance | Supports method-transparency review |
| Peptide COA context | HPLC, LC-MS, and MS can support peptide purity and identity review [18] [19] [20] | Analytical literature | Relevant to adjacent peptide research documentation |
Search intent can add useful signals, such as interest in COA access or supplier review. It can also distort the page when commercial terms invite consumer-facing assumptions.
The remedy is structure. A good product page answers procurement intent with research documentation.
Study context belongs in the evidence lane. Product positioning belongs in the documentation lane.
When these lanes merge, research pages can drift into product performance language. RUO copy should keep the focus on identity, COA records, analytical methods, lot traceability, and labeling.
Claim boundaries protect the page from turning scientific or official-source context into a claim about the material sold. Some phrases, including clinical-use language or product performance language, can create risk if they are separated from documentation and presented as product positioning.
For bacteriostatic water, the safe center is narrow and clear: composition, COA, sterile-material records, preservative identity, supplier documentation, and lot traceability.
Product-page copy should keep literature context separate from product claims. It should also separate official label terminology from Pure Lab Peptides’ RUO positioning.
That means an article may discuss what a DailyMed record says, but it should not imply that an RUO product is being positioned for the same setting as that record.
Commercial language becomes safer when every claim resolves back to documentation. “Available documentation,” “batch-specific COA,” “lot number,” and “RUO label” are stronger than broad claims.
For research procurement, a document-backed page is more useful than a hype-heavy page.
COA documentation matters because it connects a product listing to a specific batch record. FDA’s 21 CFR § 211.84 requires testing or examination of components, containers, and closures in regulated manufacturing settings and allows supplier reports under specified conditions [12].
A research page can borrow the documentation logic without claiming regulated-product status. The practical question is whether the COA is specific, current, legible, and tied to the listed material.
A certificate of analysis should identify the material name, lot or batch number, test date, method references, results, acceptance criteria when applicable, and lab or supplier source. For bacteriostatic water, useful fields may include appearance, pH, preservative identity, sterile-material status, endotoxin-related status if tested, and container notes.
A generic COA is less useful than a batch-specific COA. The product page should make that difference easy to understand.
Batch-specific records help research teams connect the physical catalog item to the document set. 21 CFR § 211.184 describes records for components, containers, closures, and labeling, including lot identity, supplier lot numbers when known, receipt date, and test or examination results [13].
That regulatory source is not a claim about RUO products. It is a useful model for why lot-level documentation matters.
Analytical testing can confirm different things depending on the method. Some tests address composition or identity, some address purity, and some address sterility-related or endotoxin-related documentation.
ICH Q2(R2) provides a framework for analytical procedure validation, and ICH Q14 describes science- and risk-based analytical procedure development [16] [17].
Documentation-focused lab-test verification protocol:
Verify the compound or material name, lot number, and label match across documents.
Review the batch-specific COA.
Check whether the purity or identity testing method is listed.
Confirm whether identity testing is supported by a suitable analytical method.
Review chromatogram or mass data when available.
Check the COA date and lab source.
Document storage and handling requirements in a laboratory record.
HPLC supports purity review by separating sample components under defined conditions. In synthetic peptide analysis, reversed-phase HPLC has been used to assess peptide purity, and the details of the method matter for interpretation [19].
For bacteriostatic water pages, HPLC may be more relevant to adjacent peptide COA review than to the water listing itself. The editorial goal is to explain what method transparency means.
LC-MS can support identity review when a material or peptide record requires mass-based confirmation. A Methods in Molecular Biology source notes that mass spectrometry is well suited for synthetic peptide identity and purity analysis, including LC-MS approaches [18].
For peptide COAs, LC-MS helps answer whether the documented material matches the expected molecular identity. For bacteriostatic water, the key is whether the supplier’s testing method matches the attribute being claimed.
Lot traceability lets a research team connect a product label, COA, supplier record, and receiving log. 21 CFR § 211.188 describes batch production and control records as complete information related to each batch, including dates, component batches, laboratory control results, packaging and labeling records, and container descriptions [14].
For RUO procurement, lot traceability supports internal recordkeeping. It also helps laboratory teams avoid treating one document as if it applies to every catalog item.
A lot number is only useful if it matches the rest of the document trail. A COA with no matching lot number cannot provide the same level of traceability as a lot-specific record.
This is where research buyers should compare the label, COA, supplier record, and receiving log. If any detail conflicts, the product page should not ask the reader to assume alignment.
Chain-of-custody documentation gives research teams a clearer record of what arrived, when it arrived, and how it was cataloged. FDA process-validation guidance emphasizes lifecycle thinking and process knowledge in regulated manufacturing contexts, which supports the broader principle that documentation should remain connected over time [15].
For RUO materials, that principle translates into careful receiving records, lot matching, and document archiving.
Before buying bacteriostatic water for research, supplier documentation should show RUO status, product identity, preservative context, COA access, lot-specific records, storage notes, and a clear supplier contact path. The page should also avoid unsupported claims that move away from research procurement.
A documentation-first supplier page helps technical buyers make a cleaner decision.
Research buyers should compare the availability and quality of documentation, not marketing intensity. Useful comparison points include COA specificity, lot number match, method transparency, storage notes, product label clarity, and supplier responsiveness.
A practical checklist:
Verify that the material is labeled for research use only.
Review the batch-specific certificate of analysis.
Confirm that the stated preservative identity matches the product description.
Check that the lot number on the COA matches the product documentation.
Compare sterile water, saline, and bacteriostatic water language only in technical context.
Assess whether the product page avoids personal-use, clinical-use, or therapeutic claims.
Document storage and handling conditions in a laboratory record.
Sterile vials, bottles, and container records should match the COA and product label. FDA guidance on container and closure integrity explains that sterile products are expected to remain free from viable microbial contamination through their stated shelf life and discusses container-closure integrity as part of sterile-product stability strategy [9].
For RUO product pages, container-format details should be descriptive and documentation-based.
Storage and handling documentation should cover the supplier’s stated temperature range, light exposure notes when listed, container condition, seal status, receiving date, and internal cataloging record. Official label records can include storage ranges and pH ranges, which are technical label details rather than RUO product claims [1].
Pure Lab Peptides product-page copy should keep storage language general and documentation-led.
Temperature records help lab teams document whether receiving and storage conditions match the supplier’s stated instructions. They are part of a records process, not a personal-use instruction.
For internal procurement, the receiving log should capture arrival condition, date, storage location, and any discrepancy between supplier notes and internal records.
Vial condition notes belong in receiving logs because they create a contemporaneous record. If a seal, label, or container appears inconsistent, the lab team can document the issue before cataloging the material.
That record supports accountability. It also prevents later confusion between product identity, container condition, and batch documentation.
Misunderstandings usually come from mixing search language with technical documentation. A product page can reduce confusion by defining the material, separating look-alike terms, and making COA expectations clear.
Common misunderstandings include:
Published or official-source terminology does not equal product-use guidance.
A sterile label term does not automatically describe endotoxin documentation.
A purity percentage does not prove complete identity without method context.
A COA should be batch-specific, not generic.
Container-size language is catalog information, not a research conclusion.
Boundary-sensitive search terms should not become product claims.
Sterile water comparisons without context can mislead readers. A preservative-free sterile water record differs from a bacteriostatic water record because the preservative status differs [1] [2].
That does not make one page a procedural guide. It simply shows why exact label language matters.
Container-format terms should identify the package, not imply product direction. The safest product page describes whether the material appears in a vial or bottle and then ties that format back to records.
If a label or catalog listing includes a volume, it should remain a catalog specification. It should not be turned into a separate SEO target.
Final documentation review should bring the page back to the basics: RUO label, identity record, COA, lot number, supplier record, sterile-material documentation, storage notes, and receiving-log plan. The best procurement decision is documentation-led.
Research-use-only notice:
“Pure Lab Peptides supplies compounds for laboratory research use only. Products are not intended for human or animal consumption, diagnostic use, therapeutic use, clinical use, veterinary use, or as food, drugs, cosmetics, dietary supplements, or household products. Researchers are responsible for ensuring lawful, appropriate handling and use in accordance with applicable regulations and institutional guidelines.”
Before cataloging, lab teams should confirm the material name, lot number, COA, supplier record, storage notes, and RUO label. Data-integrity guidance from FDA emphasizes reliable and accurate records in CGMP contexts, which reinforces the general value of careful documentation practice [11].
The result is a cleaner internal record. It also makes future review easier if the product page, COA, or label changes.
The next step is to review the product-page documentation, COA details, and RUO labeling before evaluating bacteriostatic water for laboratory research procurement. For research teams comparing suppliers, prioritize transparent labeling, batch-specific documentation, and lot-level traceability.
Explore Pure Lab Peptides for RUO peptide compounds with research-focused product information and available documentation.
Bacteriostatic water is documented as a sterile aqueous laboratory material that contains benzyl alcohol in official label context [1]. For RUO product pages, the key review points are identity language, preservative documentation, COA availability, lot number consistency, and storage records. Researchers should treat it as a laboratory material record, not as product-positioning language.
Bacteriostatic water and sterile water differ mainly in preservative documentation. Bacteriostatic water is associated with benzyl alcohol in official label context, while preservative-free sterile water records distinguish materials without a bacteriostat [1] [2]. For research buyers, the safest comparison is technical: review the label, COA, lot record, and supplier documentation before procurement.
The phrase bacteriostatic preservative matters because it helps identify the preservative role within the product record. If a material is formulated with benzyl alcohol, that detail should appear consistently across the label, COA, and supplier documentation. On an RUO page, preservative language should stay tied to identity and documentation rather than product claims.
Researchers should check RUO labeling, COA availability, lot number matching, preservative identity, storage documentation, and supplier records before they buy bacteriostatic water for research. The goal is to confirm that the product page, batch-specific documentation, and receiving records align. A documentation-first review helps keep procurement focused on laboratory research requirements.
Expiration date information should be handled as part of the product documentation record. Researchers should compare the product label, COA, supplier listing, and internal receiving log to confirm the same material and lot are being reviewed. The expiration date should not be treated as a substitute for COA review, storage documentation, or lot traceability.
Sterile diluent language is important because peptide research documentation often depends on clear separation between the research material record and the solvent record. When water as a diluent appears near peptide listings, the page should keep identity, preservative status, COA review, and lot traceability distinct. This keeps the product page research-focused and RUO-safe.
The following authors are recognized for published research that helped shape the scientific context discussed in this article.
Author profile: University of Southern Denmark Profile
Peter Højrup’s published work is relevant to the analytical framework behind this documentation-focused article. His publications on peptide amino acid analysis and mass spectrometry provide context for how laboratory teams can think about composition records, peptide identity, molecular-weight confirmation, and analytical characterization without turning method literature into product claims. That background connects to the article’s emphasis on COA review, batch documentation, and method transparency for RUO product-page evaluation. His work is most relevant here as part of the broader peptide analytical literature that informs how identity and purity records are interpreted in a research procurement setting.
Selected publications:
Analysis of Peptides and Conjugates by Amino Acid Analysis – Methods in Molecular Biology, 2015. DOI: 10.1007/978-1-4939-2999-3_8
Characterization of Synthetic Peptides by Mass Spectrometry – Methods in Molecular Biology, 2015. DOI: 10.1007/978-1-4939-2999-3_9
Author profile: Gustavus Adolphus College Profile
Dwight R. Stoll’s chromatography publications are relevant to the article’s discussion of HPLC, LC-MS, and analytical-documentation review. His work on two-dimensional liquid chromatography helps frame why method selection, peak-purity assessment, chromatographic separation, and mass-based confirmation can matter when research teams evaluate peptide-related COA records. In this bacteriostatic water article, that literature is applied only as analytical context for documentation review and adjacent peptide research listings. It supports a careful distinction between laboratory method interpretation and product claims, keeping the page focused on research materials, supplier records, and lot-level documentation workflows.
Selected publications:
A two-dimensional LC-MS publication on peptide peak-purity review, Part I – Journal of Chromatography A, 2023. DOI: 10.1016/j.chroma.2023.463874
A two-dimensional LC-MS publication on peptide peak-purity review, Part II – Journal of Chromatography A, 2023. DOI: 10.1016/j.chroma.2023.463873
DailyMed. Official label record for bacteriostatic water sterile diluent. U.S. National Library of Medicine. Updated 2024.
DailyMed. Official label record for preservative-free sterile water. U.S. National Library of Medicine. Updated 2025.
DailyMed. Official label record for preserved saline solution. U.S. National Library of Medicine. Updated 2024.
National Center for Biotechnology Information. PubChem Compound Summary: Water. PubChem. Updated 2026.
National Center for Biotechnology Information. PubChem Compound Summary: Benzyl Alcohol. PubChem. Updated 2026.
National Center for Biotechnology Information. PubChem Compound Summary: Sodium Chloride. PubChem. Updated 2026.
United States Pharmacopeia. General Chapter 〈71〉 Sterility Tests. USP–NF. 2017.
United States Pharmacopeia. General Chapter 〈85〉 Bacterial Endotoxins Test. USP–NF. 2017.
U.S. Food and Drug Administration. Container and closure system integrity testing guidance. FDA Guidance Document. 2008.
U.S. Food and Drug Administration. Sterile material manufacturing quality guidance. FDA Guidance Document. 2004.
U.S. Food and Drug Administration. Data Integrity and Compliance With CGMP: Questions and Answers. FDA Guidance Document. 2018.
Cornell Legal Information Institute. 21 CFR § 211.84 — Testing and approval or rejection of components, containers, and closures. Electronic Code of Federal Regulations.
Cornell Legal Information Institute. 21 CFR § 211.184 — Component, container, closure, and labeling records. Electronic Code of Federal Regulations.
Cornell Legal Information Institute. 21 CFR § 211.188 — Batch production and control records. Electronic Code of Federal Regulations.
U.S. Food and Drug Administration. Process Validation: General Principles and Practices. FDA Guidance Document. 2011.
U.S. Food and Drug Administration. Q2(R2) Validation of Analytical Procedures. ICH/FDA Guidance. 2024.
U.S. Food and Drug Administration. Q14 Analytical Procedure Development. ICH/FDA Guidance. 2024.
Prabhala BK, Mirza O, Højrup P, Hansen PR. Characterization of Synthetic Peptides by Mass Spectrometry. Methods in Molecular Biology. 2015. DOI: 10.1007/978-1-4939-2999-3_9. PMID: 26424265.
Bizanek R, Manes JD, Fujinari EM. Purity assessment of synthetic peptides by reversed-phase HPLC. Peptide Research. 1996. PMID: 8727482.
Petersson P, Buckenmaier S, Euerby MR, Stoll DR. Two-dimensional liquid chromatography and mass spectrometry for pharmaceutical peptide peak purity. Journal of Chromatography A. 2023. DOI: 10.1016/j.chroma.2023.463874. PMID: 36841023.
This research disclaimer clarifies how this page handles published literature and search language around bacteriostatic water. In laboratory reagent and diluent documentation content, phrases such as bac water, Hospira, hospira bacteriostatic water, pharmaceutical-grade bacteriostatic water, trusted source, pharmacy, and sodium chloride 0.9% can drift into consumer-facing, administration-focused, clinical-use, or product-claim language when framed incorrectly. Catalog terms such as 30ml, 10ml, and 28 days should also remain documentation context rather than product-positioning language.
Here, those phrases are handled only as research-language examples, not product uses, outcomes, instructions, or recommendations. The focus remains on bacteriostatic water identity, COA review, analytical testing, peptide purity context, lot traceability, RUO labeling, product documentation, and published literature boundaries. Terms such as bacteriostatic water is intended and bacteriostatic water can be used require careful separation from product claims, while phrases like benzyl alcohol prevents or helps maintain sterility should be tied back to documented preservative identity rather than standalone claims.
Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.
Discount Applied Successfully!
Your savings have been added to the cart.
There are no reviews yet.